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ahis year has been one in which there have been important
evelopments related to the entire spectrum of the fetus to
he older adult with congenital heart disease (CHD). I have
ried to group these papers in age-related categories. I
elieve this is an indication of how the management of
atients with CHD now encompasses this ever-enlarging
atient population from the beginnings of life until middle
o late adulthood.
ETAL CARDIOLOGY
woretzky et al. (1) reported results of management of 24
etuses predicted to progress to hypoplastic left heart syn-
rome (HLHS) if left untreated. Twenty underwent at-
empted dilation of aortic stenosis (AS) with technical
uccess in 14. Fetal echocardiograms after intervention
emonstrated growth arrest of left heart structure in unsuc-
essful cases, and in those who declined the procedure.
ignificant left heart growth was seen in successful cases
hich resulted in a two-ventricle circulation at birth in three
eonates. Performing this procedure is a real tour-de-force
equiring the collaboration of a dedicated team. Although
omplications and mortality were high, this study demon-
trates the feasibility of this intervention for selected fetuses
t risk for developing HLHS.
Marshall et al. (2), with the same group of investigators,
eport atrial septal defect (ASD) creation or enlargement in
etuses with HLHS and intact or highly restrictive atrial
eptum. These infants are known to have severe early
ostnatal distress. Ultrasound-guided fetal atrial septoplasty
onsisting of septal puncture and ASD dilation was found to
e feasible in six of seven patients. There was one fetal death
fter the procedure; the remaining fetuses were live born at
erm. Although technically feasible, the real dilemma is
hether these fetuses would be benefit by going to term
ith intervention immediately after birth or in utero. We
ould need detailed data on pulmonary vascular assistance
nd/or pulmonary venous images to better understand
hether the early intervention reduces risk.
Rychik et al. (3) used echocardiography to evaluate heart
unction before, during, and early after fetal surgery for
oncardiac congenital anomalies in 83 fetuses at a mean
estational age of 23 weeks. Heart rate increased acutely and
ombined cardiac output diminished at the time of fetal
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005; accepted April 5, 2005.ncision for all groups. Ventricular dysfunction and valvular
ysfunction were identified in all groups as well as acute
onstriction of the ductus arteriosus. These acute changes
ndicate the importance of echocardiographic monitoring in
he management of patients with severe congenital anom-
lies who can benefit from fetal surgery.
Jaeggi et al. (4) report on a standardized treatment
pproach including administration of maternal dexametha-
one and beta stimulation for complete atrioventricular
lock (CAVB) and fetal heart rates 55 beats/min. There
ere 37 consecutive cases of fetal CAVB. The age at
iagnosis was 26 weeks, and in 92% maternal autoantibod-
es were present. This therapy remarkably improved the
urvival rate and decreased the incidence of immune-
ediated conditions such as myocarditis, hepatitis, and
ardiomyopathy.
EONATAL AND INFANT CARDIOLOGY
lahos et al. (5) report a 13-year experience treating HLHS
nfants with intact or very restrictive atrial septum. There
ere 33 newborns that underwent urgent/semiurgent cath-
terization to create or enlarge an ASD before surgical
alliation. Preoperative and early postoperative mortality
as 48% with 7 of 33 dying before surgery compared with
of 66 control HLHS patients without restrictive ASD.
reedom from death at six months was 42% in patients with
estrictive ASD and 79% in control HLHS patients. This
tudy lends support to fetal intervention in these patients
2). However, there is still room for comparison of current
ay management of immediate postnatal septostomy with
etal intervention.
Sano et al. (6) report a multi-institutional study on
rst-stage palliation of HLHS using a right ventricle-to-
ulmonary artery (RV-PA) shunt. There were 61 (84%)
ospital survivors, including 5 of 6 patients weighing2 kg,
nd 8 late deaths. Risk factors for hospital mortality in-
luded preoperative treatment without ventilatory support
nd surgeon’s experience for the first 10 cases. These
uthors report improved survival with this procedure but
learly show the effects of a learning curve for this modifi-
ation of HLHS first-stage palliation.There is still contro-
ersy about whether RV-PA versus standard first-stage
alliation using an aorta-to-pulmonary artery (AO-PA)
hunt is the better operation for these infants.
Tanoue et al. (7) report on measures of contractility and
fterload as well as right ventricular efficiency in 21 HLHS
atients who underwent both the bidirectional cavopulmo-
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Year in Congenital Heart Disease June 7, 2005:1887–99ary connection (BCPC) and a total cavopulmonary con-
ection (TCPC) after initial Norwood palliation. Eleven
atients initially had the AO-PA shunt, and 10 had the
V-PA modification. Data was obtained at cardiac cathe-
erization before and after the BCPC and approximately
ne year after TCPC. Mid-term ventricular performance of
he RV-PA conduit group was comparable with the
O-PA shunt group in terms of ventricular efficiency.
owever, after the BCPC, contractility in patients with an
V-PA connection was inferior to that in patients with an
O-PA shunt. Although the difference in contractility was
mall, this study raises concern about the effect of right
entriculotomy on ventricular function. Further studies of
entricular performance and contractility in patients after
alliation for HLHS will be important with attempts to
atch patients with similar risk factors in both groups
ncluding cross-clamp time, valvular insufficiency, and af-
erload excess.
Fenton et al. (8) studied 35 infants who underwent
lacement of AO-PA shunts for pulmonary atresia with
ntact ventricular septum. The right ventricles were severely
ypoplastic in 22 of 35 infants, and hospital death occurred
n 2 patients, 1 with severe hypoplasia. There are a total of
deaths after discharge and before second-stage operation
n the remaining 33 patients. All had severe right ventricular
ypoplasia. There were two deaths after second-stage op-
ration. This interim mortality rate is similar to that in
LHS, and must be considered when different manage-
ent options are considered. Shunt thrombosis and myo-
ardial infarction accounted for four of five infant deaths.
Sittiwangkul et al. (9) studied 225 consecutive patients
ith tricuspid atresia between 1971 and 1999. There was no
ignificant change in Fontan operative mortality over this
eriod. Total survival was 90% at age 1 month, 70% at 10
ears, and 60% at 20 years. There were 7 early deaths, 11
ate deaths, and 3 patients progressing to heart transplan-
ation.
This report is discouraging in terms of the continued slow
ortality with time in patients who we usually consider as
ood candidates for the Fontan operation. These authors
oted a significant incidence of shunt thrombosis even in
atients on aspirin. They suggest an aggressive interstage
ome surveillance program including monitoring weight
ain, oxygen saturation, and early symptomology. In addi-
ion, early caval shunting is suggested as another means to
revent this interim mortality.
Alwi et al. (10) studied patients with duct-dependant
ulmonary circulation who underwent catheterization with
he intent of patent ductus arteriosus (PDA) stenting as first
alliation. Successful PDA stenting was performed in 51
atients (91%) and failed in 5 patients. Morbidity included
tent dislodgement with migration to the left femoral artery
n one patient and transient intravascular hemolysis in
nother patient. There was no procedure-related mortality.
t follow-up from three months to two years, eight patients
eveloped significant stent stenosis requiring re- nntervention. Seven patients developed worsening of pre-
xisting branch pulmonary artery stenosis. This experience
ith PDA stenting indicates the potential usefulness of this
echnique in patients who do not have pulmonary artery
tenosis at or near the PDA. This technique requires a great
eal of skill and experience, as well as careful monitoring
fter intervention because the ductus may narrow with time.
t can be an attractive alternative for avoiding early opera-
ion and then proceeding to an early cavopulmonary shunt
or selected patients (Figs. 1 and 2).
Batra et al. (11) studied the site of systemic pulmonary
rtery shunt insertion and growth of pulmonary arteries. A
otal of 101 patients with modified Blalock-Taussig shunts
ere evaluated. With shunts to the right pulmonary artery
nd no antegrade pulmonary flow, the left pulmonary artery
as significantly smaller than when the distal connection
as to the main pulmonary artery. Absence of antegrade
ulmonary flow resulted in significantly smaller right and
eft pulmonary sizes in general. These studies suggest that,
n the absence of antegrade pulmonary flow, a modified
lalock-Taussig shunt to the main pulmonary artery may
romote more uniform growth in branch pulmonary arteries
nd be particularly important in patients with univentricular
alliation with subsequent cavopulmonary shunts and Fon-
an procedures.
Dibardino et al. (12) report results in 125 consecutive
eonatal and infant arterial switch operations for transpo-
ition (TGA) performed between 1995 and 2003. A total of
3% had intact ventricular septum, 30% had ventricular
eptal defect (VSD), and 7% had Taussig-Bing anomaly.
he 30-day mortality was 1.6% with two late deaths, and
verall actuarial survival rate was 96.3% at 7 years. The
ncidence of complex coronary ostial origin and branching,
ncluding single coronary in 6.4% and intramural coronary
rtery in 6.4%, was not associated with increased operative
isk. All patients were without symptoms at the latest
ollow-up. There were no late coronary events, and 5.8%
ave required cardiovascular reoperation at an average of 15
onths. These patients are mostly free from clinically
pparent complications. Pulmonary artery stenosis, aortic
oot dilation, aortic insufficiency, and asymptomatic coro-
ary occlusion do occur, and surveillance for these potential
roblems is needed.
McMahon et al. (13) report on risk factors for neo-aortic
oot enlargement and aortic regurgitation after arterial
witch operation. Prior pulmonary artery banding, the
resence of VSD, and Taussig-Bing banding are risk factors
or severe aortic root enlargement. Surgical intervention for
ortic regurgitation was rare, only 2% in this cohort of 119
atients.
Mohammadi et al. (14) report on left-sided lesions in 109
f 120 survivors after anatomic repair of TGA, VSD, and
oarctation. Two-stage repair was performed in 42 patients
nd single-stage repair was performed in 67 patients. Early
nd late survivals were better for those patients who had
eonatal single-stage repair with pulmonary homograft
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June 7, 2005:1887–99 Year in Congenital Heart Diseaseortic augmentation. Despite neoaortic root enlargement,
ost patients had trivial or mild aortic regurgitation. Re-
oarctation required angioplasty in nine patients and repeat
urgery in nine patients. There were two late deaths from
oronary artery stenosis and myocardial infarction. Subaor-
ic stenosis developed in seven patients with four deaths.
his was mainly due to VSD malalignment and, therefore,
isease-related. It is an important postoperative complica-
ion to be aware of.
Burch et al. (15) report on persistent pulmonary hyper-
ension late after neonatal aortic valvotomy. This rare
omplication of treatment for neonatal AS appears to be
elated to severe left ventricular diastolic dysfunction with
reserved systolic function. This restriction to left ventric-
lar filling fortunately is rare but very difficult to treat
edically. Whether or not left ventricular endocardial
esection would be useful for these patients or whether they
ill require heart or heart/lung transplantation is unclear.
urther follow-up on these rare patients with attempts to
etermine optimal strategy is needed.
Vandekerckhove et al. (16) report on the closure of a
DA with indomethacin in two infants with excessive
ulmonary blood flow and associated CHD. Both were
ull-term, one born at 39 weeks and one at 41 weeks
igure 1. Transcatheter approaches of stent implantation. (a and b) Pre
uiding Judkin’s right catheter was passed through ventricular septal defe
istal pulmonary artery; (c) normal ductus morphology in tricuspid atresia;
ermission from Alwi et al. (10).estation. Indomethacin was given on day 14 in one infant ifter an AO-PA shunt for tricuspid and pulmonary atresia.
losure of PDA was confirmed 24 h later. The second
nfant had right heart hypoplasia and had an AO-PA shunt
erformed on day 3. Because of excessive pulmonary flow,
ndomethacin was given and the PDA closed.
Whether or not these case reports indicate that a PDA
an respond to indomethacin in full-term infants is unclear.
t does appear that there was a response in these two cases,
lthough one would have to have more evidence to be
bsolutely certain that spontaneous PDA constriction did
ot occur. Nevertheless, this represents a potential new
aradigm, and further use of this modality may be indicated
n selected term infants to see if surgery can be avoided in
atients with excessive flow from a PDA.
HILDHOOD CARDIOLOGY
asso et al. (17) reported an echocardiographic study of 817
pparently healthy primary school students. Bicuspid aortic
alve (BAV) was found in 0.5% of cases with a higher
revalence in males (0.75% vs. 0.24%) and was significantly
ssociated with aortic root enlargement compared with
hildren who had tricuspid aortic valves.
Fernandes et al. (18) report on the morphology of BAV
post-stent implantation in tetralogy of Fallot-pulmonary atresia. A 6-F
anterogradely into ascending aorta with guide wire securely anchored in
st-stent implantation by retrograde transarterial approach. Reprinted with- and
ct andn a review of 1,135 patients 18 years of age who were
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Year in Congenital Heart Disease June 7, 2005:1887–99dentified by echocardiography between 1986 and 1999.
edian age was three years, and 67% of the patients were
ales. Right and left coronary leaflet fusion was the most
ommon type occurring in 70%; AS that was moderate or
reater was observed most often in patients with right
oronary/noncoronary fusion. Similarly, right coronary/
oncoronary fusion was more often associated with moder-
te or greater aortic regurgitation. The majority of patients
ith coarctation had fusion of right /left coronary leaflets.
revalence of BAV in simple coarctation was 55%, complex
oarctation was 18%, HLHS or interrupted aortic arch was
1%, and a similar prevalence to that in the general
opulation (0.6% to 0.8%) in other lesions studied.
Gurvitz et al. (19) report on aortic root dimensions and
alve dynamics in 76 children with BAV and compared
hese with values derived from 41 normal children. The
hildren with BAV had significantly larger aortic roots
egardless of the presence of AS or aortic regurgitation.
Cripe et al. (20) report on 50 probands with BAV. A
hird-generation family history and echocardiograms of
rst-degree relatives were obtained; BAV was identified in
4 individuals with a prevalence of 24%. A total of 97
igure 2. Stent stenosis. (a) In-stent stenosis: layer of neointimal prolifera
uctus arising from left subclavian artery; (c) an additional stent was imp
ermission from Alwi et al. (10).ndividuals (31%) had BAV and/or other cardiovascular qalformations including coarctation, VSD, ASD, abnormal
itral valve, aortic root dilation, or HLHS. The high
eritability of BAV suggests that, in this study population,
AV determination is almost entirely genetic. Heritability
uggests that valve formation can be primary to defective
alvulogenesis or secondary to other elements of cardiogenesis.
Cecconi et al. (21) report on dimensions of the entire
orta at different anatomic levels using two-dimensional
chocardiography in 162 consecutive patients with isolated
AV without significant aortic valve dysfunction. The
ortic dilation involved aortic root and ascending aorta but
as not present in the descending and abdominal aorta. A
ignificant increase in the dimensions of the aortic arch was
ound in patients 40 years of age.
Cattaneo et al. (22) report on surgery for aortic root
neurysm in 50 children. There was no operative or hospital
ortality. Twenty-six children had aortic root replacement
ith a composite graft, 10 patients had replacement with
omograft aortic root, and 14 patients had a David II
alve-sparing procedure. Long-term results were excellent
n the 26 children receiving a composite graft. There were
hree late deaths (11, 16, and 17 years, postoperatively). The
etween white arrows; (b) stenosis of unstented segment of a long vertical
over the stenosed and unstented segment of the ductus. Reprinted withtion buestion still remains as to when to intervene in children
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June 7, 2005:1887–99 Year in Congenital Heart Diseaseith large aortic roots. Most of these operations were done
n patients with Marfan’s syndrome. An aortic diameter of
cm with a family history of rupture/dissection or 5.5 cm
ith no other indications were used as criteria for surgery.
n children 12 years of age, these authors recommend
urgery when the aneurysm satisfies the above criteria or if
he diameter has increased 1 cm or more in 12 months. In
ddition, the emergency of aortic regurgitation is an indi-
ation for valve-sparing procedures.
McMahon et al. (23) report on risk factors for aortic valve
ysfunction and aortic regurgitation in 220 children with
iscrete subvalvar AS. Excluding patients with previous
urgical or balloon valvuloplasty, a higher maximal Doppler
radient was an independent risk factor for moderate/severe
ortic regurgitation. Independent predictors of low-risk
atients included none or trivial aortic regurgitation, peak
radient 30 mm Hg, thin and mobile aortic valve leaflets,
nd an associated VSD.
Puchalski et al. (24) report on the follow-up of hypoplasia
f left heart structures in 55 patients with isolated coarcta-
ion. All patients with isolated coarctation and mitral/aortic
alve, Z-score 2 who underwent neonatal repair were
eviewed. All patients were alive and well, and none had
vidence of mitral stenosis. Both mitral and aortic annulus
ncreased significantly; nine patients developed left ventric-
lar outflow tract obstruction by echocardiographic criteria.
espite initial annular hypoplasia, the need for intervention
or mitral stenosis or subaortic stenosis is uncommon in
atients with isolated coarctation.
Ou et al. (25) report on late systemic hypertension and
ortic geometry after successful repair of coarctation. There
as an association between a gothic type of postoperative
ortic architecture in which there is acute angulation be-
ween the ascending and descending aorta with the hori-
ontal aorta being short or absent. This type of architecture
as found in 45% of patients and was associated with a
igher prevalence of hypertension. It is unclear as to
hether or not this type of architecture alone represents an
ndependent risk factor for systemic hypertension and later
omplications. Another factor in successfully repaired co-
rctation that can lead to hypertension includes abnormal
all dynamics at the site of repair, which may not propagate
he arterial pulse normally and can result in pressure
radients with exercise when there is no anatomical con-
triction.
Nielsen et al. (26) report on cardiac magnetic resonance
maging (CMR) in 31 subjects for assessment of native or
ecurrent coarctation in terms of severity as assessed at
atheterization. The smallest aortic cross-section area ad-
usted for body surface area for CMR and heart rate
orrected mean flow deceleration to descending aorta mea-
ured by phase-velocity cine CMR showed a strong corre-
ation with predicted catheter gradient of 20 mm Hg. In
subsequent validation study, the prediction model cor-
ectly classified 9 of 10 patients with no false negatives.
hese functional parameters from CMR can provide much Tf the data needed to determine whether or not a patient
eeds intervention without the need for diagnostic cathe-
erization.
Sheikh et al. (27) report on successful conversion of
ailing Fontan atriopulmonary connections to TCPC with
nd without arrhythmia surgery in 15 patients. There was
o mortality, and average hospitalization was 18 days. At
ollow-up, atrial arrhythmias have recurred in 3 to 4 patients
ith intraatrial TCPC without ablation and in 1 of 11 with
xtracardiac TCPC with ablation. All patients are asymp-
omatic or have minimal symptoms with exercise ability
mproved by 69% on a Bruce protocol.
Nurnberg et al. (28) report on new onset arrhythmias
fter the extracardiac TCPC compared with the intraatrial
CPC for Fontan operation. Seventy-four consecutive pa-
ients received either an intra-atrial Fontan operation (29
atients) or extracardiac Fontan operation (45 patients).
edian follow-up was 4.4 years; there were five early deaths
nd one late death (a total mortality of 8%). Sinus rhythm
ersisted in 86% of extracardiac patients and 50% of
ntraatrial patients. The extracardiac Fontan operation de-
reased the incidence of post-op or new onset arrhythmias
uring early and mid-term follow-up compared with intra-
trial Fontan operation, although follow-up was shorter for
he extracardiac Fontan operation (4.4 vs. 7.9 years).
Gupta et al. (29) report on risk factors for persistent
leural effusions after the Fontan operation in 100 consec-
tive patients with a median age 3.1 years. Factors for
leural effusions lasting more than two weeks were lower
reoperative O2 saturation and the presence of postoperative
nfections. Risk factors for effusions draining at more than
0 ml/kg/day were preoperative O2 saturations, smaller
onduit size, and longer duration of cardiopulmonary by-
ass. Although this problem appears to have decreased with
taging to a Fontan procedure with a prior bidirectional
lenn as well as fenestration in any patient with high-risk
actors for morbidity or mortality, effusions continue to
lague some Fontan patients.
Wu and Huang (30) report on a new procedure for
bstein’s anomaly in 34 consecutive patients operated at a
ean of 17 years. Tricuspid regurgitation (TR) was mod-
rate in 12 patients and severe in 22 patients. The repair
echnique includes detaching the displaced posterior leaflet
ith chordae tendineae and corresponding papillary muscle
nd then reattaching to the native posterior annulus and
eimplantation of the papillary muscle. All patients survived
r recovered uneventfully. Echocardiography showed TR
isappeared in 29 patients, and was mild in 5 patients. This
rocedure needs further follow-up data, and one wonders if
t can be produced by other centers. It is unclear what the
natomical and hemodynamic factors are, which makes this
n attractive operation for certain Ebstein patients.
Chen et al. (31) report early and mid-term results for 25
atients who underwent repair of Ebstein’s anomaly at an
verage age of 14 years and average follow-up of 4 years.
he technique consisted of vertical applications of the
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Year in Congenital Heart Disease June 7, 2005:1887–99trialized ventricle and leaflet reimplantation after clockwise
otation. Three required re-operation. Eighteen children
95%) and five adults (83%) demonstrated significant im-
rovement in exercise capacity late postoperatively. Two
hildren died suddenly 11 months and 4 years after repair. It
s not absolutely clear when is the best time to intervene in
atients with moderate Ebstein’s anomaly with moderate
ight ventricular dilation. Right ventricular dysfunction
ertainly can occur with long-standing volume overload, and
ne wants to avoid getting to this point before operation.
Hraska et al. (32) report on 123 patients with congenitally
orrected TGA (CCTGA) and 2 patients with functional
entricles who underwent either a traditional two-ventricle
epair or Fontan procedure. Five-, 10-, and 15-year survivals
ere 75%, 68%, and 61%, respectively. Patients requiring
ricuspid valve replacements anytime during follow-up had a
ignificantly worse outcome, whereas the best outcome was
een in patients undergoing the Fontan procedure. Right
entricle end-diastolic pressure 17 before the operation,
omplete heart block after the operation, subvalvular pul-
onary stenosis, Ebstein malformation of the tricuspid
alve, and preoperative systemic right ventricle dysfunction
ere identified as risk factors for death at any time. The
ong-term outcome of patients with corrected TGA after
lassical approaches is frequently unsatisfactory. Alternative
pproaches such as the double-switch, Senning-Rastelli, or
ontan procedure may achieve better long-term results,
specially in the high-risk groups.
Knauth et al. (33) report transcatheter device closure of
ongenital postoperative VSDs in 170 patients using suc-
essive generations of the STARFlex-type device (NMT
edical, Inc., Boston, Massachusetts). Between one and
even devices were placed per patient (median, one) with
ultiple devices placed in 40%. There was a significant
ecrease in left-to-right shunt after the device implantation
nd significant improvement in VSD size/severity, and
evice position proved stable. Of 332 adverse events, 39
ere related to the device, and 261 were related to cathe-
erization. At a median follow-up of 24 months, 14 patients
ad died, and 18 had devices explanted. Congenital post-
perative VSD closure using these devices resulted in stable
mprovement in clinical status and decreased interventricu-
ar shunting. Although periprocedural events occurred fre-
uently, late events caused by the device were rare.
Holzer et al. (34) report on a U.S. registry of device
losure of congenital muscular VSDs using the Amplatzer
SD occluder (AGA Medical Corp., Golden Valley, Min-
esota). Data were prospectively collected from 83 proce-
ures involving 75 patients who underwent an attempt of
ercutaneous and/or periventricular (surgical) device closure
f hemodynamically significant muscular VSDs. The pa-
ients’ median age was 1.4 years. The median VSD size was
mm, and 34 of 78 patients had multiple VSDs. The device
as implanted successfully in 86.7%, and multiple devices
ere implanted in 20.5%. Procedure-related major compli-
ations occurred in 10.7%; device immobilization occurred pn two patients, and procedure-related death occurred in
wo patients. A 24-h postprocedural complete closure rate
as 47%, increasing to 70% in 6 months and 92% in 12
onths. Six patients underwent successful closure using the
eriventricular surgical approach, with complete closure at
ay 1 in three patients and trivial/small residual shunts in
he remainder. This device appears to be effective in most
atients with congenital muscular VSDs or postoperative
SDs (Fig. 3). This procedure is not for the “faint of heart,”
nd requires the work of an experienced and talented group
o perform this intervention.
Zahn et al. (35) report on interventional catheterization
erformed early postoperatively to address residual abnor-
alities in 62 patients with a mean age of four months who
nderwent 66 catheterizations on median postoperative day
. Nine patients required extracorporeal cardiopulmonary
upport. Success rates by procedure were: angioplasty,
00%; stent implantation, 87%; vascular/septal occlusion,
00%; and palliative pulmonary valvotomy, 75%. Compli-
ations included stent migration (one patient), cerebral
ascular injury (one patient), and left pulmonary artery
tenosis (one patient). Transcatheter interventions can be
uccessfully performed in the early postoperative period in
elected patients. Difficulty in ballooning or stenting cross
uture lines remains a potential hazard of this work. Results
an be extremely gratifying in selected patients (Fig. 4).
Sideris et al. (36) report total percutaneous correction of
etralogy of Fallot (TOF) variant with dominant pulmonary
alve stenosis. Two patients, ages four and seven years, with
2 saturations of 72% and 88% had severe right ventricular
utflow obstruction with dominant valvular/pulmonary ste-
osis, and large malalignment VSDs. Balloon valvuloplasty
as first performed, followed by balloon test occlusion of
he VSD and double balloon patch occlusion. After 48 h the
upporting balloons were extracted releasing the patches.
oth patients became acyanotic with O2 saturations of 96%
ith residual infundibular pulmonary stenosis (gradients 40
o 30 mm Hg). Both patients were doing well at the 6- and
2-month follow-up. This report represents an unusual
ariant of tetralogy. The VSD patch used requires 48-h
alloon support until it is embedded into the septal wall. It
s unclear that this type of patch will become the device of
hoice for percutaneous VSD closure, but this report shows
easibility in these two patients.
Novick et al. (37) report on surgical closure of a VSD in
hildren with elevated pulmonary vascular resistance using a
ouble-patch flap valve procedure. Ninety-one children
ith a median age of four years underwent VSD closure in
number of institutions worldwide by six different surgeons.
atients had elevated pulmonary vascular resistance at an
verage of 10.5 Wood units. The overall mortality rate was
of 91 or 7.7% with 7 late deaths: 2 in patients with simple
SDs and 5 in patients with complex defects. Although
atients with this type of increased pulmonary vascular
esistance are rare currently in the U.S., there are many
atients worldwide who present with significantly elevated
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June 7, 2005:1887–99 Year in Congenital Heart Diseaseulmonary vascular resistance. The use of this double-patch
echnique appears to provide some benefit in terms of
tiding them over” early postoperatively.
Chen et al. (38) report on trends and outcomes in
ransplantation for complex CHD. There were 106 patients
ho underwent transplantation and were followed for a
edian of 56 months. Thirty-seven (35%) of the patients
ied. Male gender and later year of transplantation were
rotective, and neonatal age and pulmonary artery recon-
truction were detrimental in multivariable modeling of
verall mortality. Transplantation to a physiologic or ana-
omic single lung did not impact survival. These patients
ad comparable survival estimates when compared with
hose in the entire cohort without complex CHD.
Wald et al. (39) report on 22 children with isolated
entricular noncompaction, and attempted to determine risk
actors for outcome. Echocardiographic features at presen-
ation including increased noncompacted to compacted
egment ratio and enlarged left ventricular dimension were
ound to be associated with poor outcomes including heart
ransplantation, transplant listing, or death. This diagnosis
s being made with increasing frequency, sometimes in
igure 3. Cine fluoroscopic images in a seven-month-old female baby wi
ercutaneous device closure. (A) Left ventricular (LV) angiogram in the fou
uoroscopic image in the straight frontal projection, demonstrating the gu
nferior vena cava. The wire was snared from there and exteriorized into the
nside (arrow), passing from the right internal jugular vein through the VS
gainst the septum (arrow). (E) Left ventricular angiogram confirms good
nd RV disk (arrow). (G) Cine fluoroscopic image after the device was rele
hunting through the device. Reprinted with permission from Holzer et asymptomatic or minimally symptomatic patients. Further tata are needed on patients with minimal symptomology to
etermine what is the best management strategy for this
omplex condition.
Pappone et al. (40) report a randomized study in which
rophylactic radiofrequency ablation of accessory pathways
as compared with no ablation in asymptomatic children
ge 5 to 12 years with Wolff-Parkinson-White syndrome
ho were deemed high-risk by electrophysiological testing.
he primary end point was the occurrence of arrhythmic
vents. Twenty patients underwent prophylactic ablation,
7 had no treatment; characteristics of the two groups were
imilar. There were three ablation-related complications,
ne of which lead to hospitalization during follow-up. One
hild in the ablation group (5%) and 12 in the control group
44%) had arrhythmic events. Two children in the control
roup had ventricular fibrillation, and one died suddenly. In
symptomatic high-risk children with Wolff-Parkinson-
hite syndrome, prophylactic catheter ablation performed
y an experienced operator may reduce the risk of life-
hreatening arrhythmias. This represents a major deviation
rom current practice in most centers.
Strieper et al. (41) report on cardiac resynchronization
gle muscular ventricular septal defect (VSD), demonstrating the steps of
mber view, demonstrating a 6-mm mid-muscular VSD (arrow). (B) Cine
ire (arrow) across the VSD into the right ventricular (RV) and down the
internal jugular vein. (C)Delivery sheath with an 8-mm Amplatzer device
terminating into the LV. (D) The LV disk is being deployed and pulled
sk position. (F) Cine angiogram after deployment of the connecting waist
(H) Final LV angiogram confirming good device position and no residual
).th sin
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LV diherapy (CRT) for ventricular dysfunction in seven patients
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Year in Congenital Heart Disease June 7, 2005:1887–99ith complex CHD. The prepacing QRS duration ranged
rom 120 to 280 ms and post-CRT from 80 to 180 ms.
jection fraction improved from a mean 16% to 36%, and
eft ventricular dimension decreased from 5.9 to 4.8 cm.
his study demonstrates that there appears to be a role for
RT in young patients with dilated cardiac myopathy,
ongestive heart failure, and congenital heart defects.
Janousek et al. (42) report on CRT in eight patients with
systemic right ventricle and right bundle branch block
ith QRS averaging 161 ms; CRT resulted in QRS
ecreasing by 28%, filling time improving by 11%, right
entricle maximum dP/dt increasing by 46%, aortic velocity
ime interval increasing by 7%, and right ventricle ejection
igure 4. (A) Right ventricular angiogram performed via a sheath (black
sterisk) placed directly into the right ventricular outflow tract (RVOT) via
n open sternum in a four-month-old 6 h after RVOT reconstruction and
ulmonary arterioplasty. Note the severe proximal left pulmonary artery
tenosis (black arrowhead) at the anastomosis with the RVOT patch. (B)
fter stent placement, there has been complete relief of the stenosis
ithout evidence for vascular disruption. Reprinted with permission from
ahn et al. (35).raction increasing by 10%. Right ventricle fractional area Change increased from of 18% to 29.5% at last follow-up
ithout a change to the end-diastolic area. Cardiac resyn-
hronization therapy appears to be useful as a promising
djunct to the treatment and prevention of systemic right
entricular failure in patients with a systemic right ventricle.
Bacha et al. (43) report on cardiac CRT in 26 single-
entricle patients with a mean age of 28 months. Three-
imensional data were analyzed to obtain regional volume-
ime curves for 16 three-dimensional segments of the
ystemic ventricle. Multisite pacing performed on median
ostoperative day 2 resulted in QRS duration decreasing
rom 94 to 72 ms, systolic blood pressure increasing from 86
o 94 mm Hg, cardiac index increasing from 3.2 to 3.7, and
he index of asynchrony improving in 8 of 10 patients; CRT
ay improve ventricular performance after single-ventricle
alliation.
DULT CHD
eldtman et al. (44) report on outcomes of pregnancy in
3 women with TOF who had 112 pregnancies. Eight
omen had unrepaired TOF. At first assessment, 6
atients had pulmonary hypertension, 3 had moderate or
evere right ventricular systolic dysfunction, and 13 had
evere right ventricular dilation due to pulmonary regur-
itation. Sixteen patients had 30 miscarriages and 1 term
tillbirth. Mean overall birth weight was 3.2 kg. Unre-
aired TOF and morphologic pulmonary artery abnor-
ality were independently predictive of infant birth
eight. Six patients had cardiovascular complications:
upraventricular tachycardia (SVT) in two, heart failure
n two, pulmonary embolism in one, and progressive right
entricular dilation in one. Five infants (6%) had con-
enital anomalies. Patients with TOF have an increased
isk of fetal loss, and offspring are more likely to have
ongenital anomalies than the general population. Ad-
erse maternal events, although rare, may be associated
ith left ventricular dysfunction, severe pulmonary hy-
ertension, and severe pulmonic regurgitation with right
entricular dysfunction. Most patients with TOF who
ave a reasonably good repair with normal or mildly
ecreased right ventricular function, and mild-to-
oderate pulmonary regurgitation and/or pulmonary ste-
osis, tolerate pregnancy well. This report indicates the
ifficulties that can occur in patients with more signifi-
ant abnormalities.
van Straten et al. (45) report on CMR at 7 months, and
9 months after pulmonary valve replacement in 25 consec-
tive patients with TOF. There was a marked decrease in
ight ventricular volume from 167 ml/m2 to 114 ml/m2 at 7
onths and to 112 ml/m2 at 19 months follow-up. Ejection
raction remained the same and was 43% preoperative and
7% at 19-month follow-up (p  0.1). Results are encour-
ging for early valve replacement in patients with right
entricular dilation and severe pulmonary regurgitation;
MR appears to be the most useful way for assessment of
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June 7, 2005:1887–99 Year in Congenital Heart Diseaseight ventricular size and function as well as pulmonary
rtery anatomy both before and after valve replacement.
Guedes et al. (46) report on the impact of pregnancy on
he systemic right ventricle of 16 women who completed 28
regnancies after an atrial repair for TGA. Twenty-one of
he women were asymptomatic, and two had mild symp-
oms before pregnancy. Functional class deteriorated in six,
ith no return to the prepregnancy level after delivery in
wo. Right ventricular dilation progressed in five women,
ith no recovery in all patients at the last follow-up. Right
entricular systolic dysfunction was absent in 16, mild-to-
oderate in 4, or severe in 1 before pregnancy and pro-
ressed in 4 women with no recovery in three cases. The TR
as absent in eight, mild in nine, and moderate in three
efore pregnancy and deteriorated in eight women with no
ecovery in three patients. Pregnancy after atrial repair of
GA is clinically well tolerated in most of these patients
ho have no symptoms before pregnancy, but carries a risk
f deteriorating right ventricular function in patients with
ild-to-moderate right ventricular dilation and dysfunction
efore pregnancy.
Roos-Hesselink et al. (47) report a decline in ventricular
unction and clinical condition after atrial repair for TGA in
igure 5. Left anterior oblique projections of the ventilation (A) and perfu
), in Patient 20. This is indicative of a high probability for pulmonary emb
he computerized tomography pulmonary angiogram are shown. In the coro
obe vessels is seen, and relative paucity of contrast within the upper lobe p
ndoluminal filling defect, in keeping with thrombus, is shown within a
onocclusive thrombus is also seen in this patient in a lower lobe pulmona1 consecutive patients operated on between 1973 and fi980. While all patients had good right ventricular function
4 years after repair, 61% of patients showed moderate-to-
evere dysfunction after 25 years when studied by echocar-
iography. In addition, the QRS complex widened, and
xercise capacity decreased.
Kammeraad et al. (48) report on 47 patients after atrial
epair of TGA who experienced a sudden death event with
4 being sudden death and 13 being near-miss sudden
eath. Each patient was matched with two controls with the
ame operation without a sudden death event. Presence of
ymptoms of arrhythmia, or heart failure at most recent
ollow-up, or history of documented atrial flutter or atrial
brillation was found to increase the risk of sudden death.
lectrocardiogram (ECG), chest X-ray, and Holter ECG
ndings were not predictive of sudden death. Neither
edication nor pacing was found to be protective; most
udden death events occurred during exercise. Recorded
entricular tachycardia/ventricular fibrillation were the re-
orded rhythm during sudden death in 21 of 47 patients.
hese authors suggest electrophysiologic study for inducible
entricular tachycardia/ventricular fibrillation in patients
resenting with symptoms or with documented atrial flut-
er/atrial fibrillation. If ventricular tachycardia/ventricular
(B) images illustrate a perfusion defect in the left upper lobe (thin arrow,
Coronal (C) and sagittal oblique (D) maximum intensity projections from
rojection (C), gradation of vessel contrast from the lower lobe to the upper
nary arteries on the left compared to the right is shown near the asterisk.
ental upper lobe pulmonary artery (dashed arrow, C and D). Incidental
tery (thick arrow, C). Reprinted with permission from Varma et al. (50).sion
olus.
nal p
ulmobrillation is induced using moderately aggressive pacing
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Year in Congenital Heart Disease June 7, 2005:1887–99rotocols, implantable cardioverter-defibrillator should be
onsidered.
van den Bosch et al. (49) report on the long-term
utcomes and quality of life in 36 adult patients after the
ontan operation. Of the initial 36 patients, 10 died at a
ean of age 10 years after the Fontan operation, and 1
atient underwent cardiac transplantation. Reoperations
ere performed in 21 patients. Sustained SVT was
bserved in 20 patients with an increase incidence of
rrhythmias with longer follow-up. Thromboembolic
vents were detected in nine patients, five of who had
dequate anticoagulant levels at the time of the event. A
otal of 195 hospital admissions were recorded, and
uality of life assessment showed physical functioning,
ental health, and general health perception to be
ignificantly lower for Fontan patients than for the
ormal Dutch population.
Varma et al. (50) report on silent emboli in adults after
he Fontan operation. Thirty consecutive adult Fontan
atients were evaluated using ventilation-perfusion scanning
nd blood testing for thrombophilia tendency. If the
entilation-perfusion (VQ) scan showed an intermediate or
igh probability for pulmonary emboli, a computerized
omographic pulmonary angiogram was performed. Thirty
atients were included in the study, and five (17%) had an
ntermediate or high probability for pulmonary emboli in
igure 6. (A) Transesophageal echocardiography showing aortic bicuspid v
alloon dilation of coarctation of the aorta. (B) Magnetic resonance ima
oarctation of the aorta. (C) This MRI shows a descending aorta giant fals
hows an abnormal bulge of aorta (aneurysm) and a false aneurysm (pseud
emoptysis, was also demonstrated (arrow). An  true aneurysm; PsA Q scans, all of which were confirmed by computed romography pulmonary angiography. No patient had a
hrombophilia tendency. Pulmonary emboli were not
resent in any patient taking warfarin. Late age at time of
ontan operation and type of Fontan anatomy were associ-
ted with increased risk of silent pulmonary emboli (Fig. 5).
Oliver et al. (51) report on 235 adults with coarctation
ho were retrospectively reviewed. Treatment by surgery
ad been performed in 181 patients or by balloon
ngioplasty or stenting in 28 patients. There were no
revious interventions in 26 patients with mild coarcta-
ion. Aortic wall complications were present in 37 pa-
ients (16%) with no difference in the three groups with
espect to total complications. Only aging and BAV were
ignificantly related to these complications (Fig. 6). It is
ncreasingly apparent that coarctation, particularly when
ssociated with BAV, is a generalized arteriopathy. These
atients need long-term follow-up, and CMR is an
xcellent way of screening for abnormalities along their
ntire aorta.
Beauchesne et al. (52) report on the prevalence of clinical
anifestations of 22 q11.2 microdeletion in adults with
elected conotruncal anomalies. There were 103 consecutive
dults who were prospectively screened for this microdele-
ion, and clinicians were asked to predict microdeletion
tatus on the basis of clinical features. Six patients (5.8%)
ad microdeletions and, in two of these, clinicians incor-
d right sinus of Valsalva aneurysm ruptured into the right atrium late after
RI) of an ascending aorta aneurysm in a patient with unrepaired mild
rysm in another patient with unrepaired mild coarctation. (D) This MRI
rysm) late after patch aortoplasty; aortobronchial fistula, causing massive
aneurysm. Reprinted with permission from Oliver et al. (51).alve an
ge (M
e aneuectly predicted absence of the deletion. In three, typical
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June 7, 2005:1887–99 Year in Congenital Heart Diseaseysmorphic features were absent (Fig. 7). Screening for
icrodeletion should be considered in adults with high-risk
ardiac lesions because of its importance in reproductive
ounseling and surveillance for associated extracardiac man-
festations.
Salehian et al. (53) report on improvements in cardiac
orm and function after transcatheter closure of secundum
SDs in 25 patients with an average age of 45 years. There
as a statistically significant improvement in right ventric-
lar myocardial performance index and left atrial volume
ndex after closure of ASD. In addition, there was an
ncrease in left ventricular size and no change in ejection
raction after closure.
Silversides et al. (54) report on symptomatic atrial
rrhythmias in 132 consecutive patients who underwent
igure 7. Facial views of two of the patients with 22q11.2 microdeletion
llustrating the spectrum of facial dysmorphism. (A) Except for mild
pper eyelid changes associated with normal aging, this 47-year-old
an does not have typical dysmorphic changes of 22q11.2 microdele-
ion. (B) This 27-year-old woman has facial features of 22q11.2
icrodeletion including a long face, paranasal bossing, and hooded
ppearance of the upper eyelids with narrow palpebral fissures. Re-
rinted with permission from Beauchesne et al. (52).ranscatheter ASD closure. Those without a history of crrhythmia had a low incidence of atrial tachycardia
uring follow-up (6%) and intermediate follow-up (1%
er year), while all patients with persistent atrial tachy-
ardia before closure remained in atrial flutter/atrial
brillation. Of patients in sinus rhythm but with a
revious history of atrial tachycardia, two-thirds re-
ained arrhythmia-free at follow-up, with overall inci-
ences of paroxysmal or persistent atrial tachycardia of
7% and 11% a year, respectively. Device closure of an
SD before the onset of atrial arrhythmias may protect
gainst the subsequent development of arrhythmia, par-
icularly in patients 55 years of age.
Azarbal et al. (55) report on 86 adult patients who
nderwent transcatheter closure of an interatrial commu-
ication. Migraine headaches were present in 42% of
atients before the procedure, and, three months after the
rocedure, the migraine headaches disappeared com-
letely in 75% of patients with migraine and aura and in
1% with migraine without aura. Of the remaining
atients, 40% had significant improvement of migraine
eadaches.
Reisman et al. (56) report on 160 consecutive patients
ith paradoxical cerebral embolism who underwent
ranscatheter patent foramen ovale closure for prevention
f recurrent cryptogenic stroke or transient ischemic
ttacks. A one-year retrospective analysis of migraine
ymptoms was performed. Preclosure, active migraine
as present in 35% of patients, and 68% experienced
igranious aura; 50 patients were available for analysis at
ne year. Complete resolution of migraine symptoms
ccurred in 56% of patients, and 14% of patients reported
ignificant reduction of migraine frequency. Patients
eported an 80% reduction in the mean number of
igraine episodes per month after patent foramen ovale
losure. These two studies suggest that intraatrial com-
unications may play a role in the etiology of migraine
eadaches either through paradoxical embolism or from
lood-borne factors bypassing the pulmonary circulation.
hese studies suggest a strong rationale for further
nvestigation of the pathophysiology and treatment of
igraine. Because both migraine and patent foramen
vale have a high frequency in the general population,
urther study of appropriately matched patients with
igraine with and without patent foramen ovale closure
ill be needed to determine whether or not this is a
ausative relationship.
UMMARY
his review emphasizes aggressive management strategies
n fetuses, infants, and children with CHD. There is an as
ngoing need for long-term follow-up, especially in adults
ith CHD, many of whom are not receiving continuity of
are. An expanded work force will need to be trained to take
are of this rapidly expanding population.
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